Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/10/2025

Mannitol Dosing for Increased Intracranial Pressure

Standard Dosing Recommendations

  • The American Academy of Pediatrics recommends administering mannitol 0.25-1 g/kg IV over 20-30 minutes for treating increased intracranial pressure, with 0.25 g/kg being as effective as higher doses for acute ICP reduction while minimizing risks of osmotic complications 1, 2, 3
  • For acute intracranial hypertensive crisis, a dose of 0.5-1 g/kg over 15 minutes may be appropriate 1, 2, 3
  • In pediatric patients, a dose of 1-2 g/kg or 30-60 g/m² body surface area over 30-60 minutes is recommended 1, 2, 3

Administration Protocol

  • The American Academy of Pediatrics suggests placing a urinary catheter before administration due to osmotic diuresis 1, 2, 3
  • Administer mannitol through a filter and do not use solutions containing crystals 1, 2, 3
  • The standard infusion rate is over 20-30 minutes 1, 2, 3, 4
  • In cases of acute crisis, infusion over 15 minutes for larger doses may be appropriate 1, 2, 3

Monitoring Requirements

  • The American Academy of Pediatrics recommends maintaining serum osmolality below 320 mOsm/L and discontinuing mannitol if serum osmolality exceeds 320 mOsm/L to prevent renal failure 4, 5
  • Monitor fluid, sodium, and chloride balance 5
  • Maintain cerebral perfusion pressure (CPP) between 60-70 mmHg during treatment 4, 5

Multimodal ICP Management

  • The American Academy of Pediatrics recommends using mannitol in conjunction with other ICP control measures, such as hyperventilation, sedation and analgesia, head-of-bed elevation, cerebrospinal fluid drainage, barbiturates, and neuromuscular blockade 1, 2, 3, 5

Alternative: Hypertonic Saline

  • The American College of Critical Care Medicine suggests that at equiosmotic doses, mannitol and hypertonic saline have comparable efficacy for ICP reduction 4, 5
  • Choose hypertonic saline when hypovolemia or hypotension is present 4, 5
  • Choose mannitol when hypernatremia exists or improved cerebral blood flow rheology is desired 5

Critical Clinical Caveats

  • The American Heart Association recommends avoiding the use of mannitol in hypotension or hypovolemia, and considering hypertonic saline instead 4
  • Mannitol can cause rebound intracranial hypertension, particularly with prolonged use or rapid discontinuation, especially when serum osmolality rises excessively 5
  • In children, mannitol may worsen intracranial hypertension by increasing cerebral blood flow if generalized cerebral hyperemia develops within 24-48 hours post-injury 5

REFERENCES

4

Mannitol Administration for Reducing Intracranial Pressure [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Management of Intracranial Hypertension with Mannitol [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025